PROCEPT BioRobotics PRCT
NASDAQ PRCT
$20.38 +0.31 (+1.54%)
As of: Sep 11, 2026 · 3:59 PM EDT

PROCEPT BioRobotics (PRCT) Short term Debt (2020)

PROCEPT BioRobotics' (PRCT) quarterly Short term Debt came in at $4.6 million in Q4 2020.

Analysis

PROCEPT BioRobotics (PRCT) Short term Debt (2020) Analysis & Trends

PROCEPT BioRobotics (PRCT) has reported Short term Debt for 1 consecutive years, with $4.6 million the latest figure, recorded in Q4 2020.

  • On a quarterly basis, Short term Debt changed N/A year-over-year to $4.6 million in Q4 2020; TTM through Dec 2020 was $4.6 million, a N/A change from a year earlier, with the FY2020 full-year figure at $4.6 million, changed N/A from the prior year.
  • Short term Debt was $4.6 million for Q4 2020 at PROCEPT BioRobotics.
  • Over five years, Short term Debt peaked at $4.6 million in Q4 2020 and troughed at $4.6 million in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn
10 PROCEPT BioRobotics 1.17 Bn 895.36 Mn 62.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 4.55 Mn